Showing results (421-430 of 856) with videos related to

Sort By:
Pageof 86
Journal of Immunology (Baltimore, Md. : 1950)|September 4, 2012
Lack of the lectin-like domain of thrombomodulin worsens Shiga toxin-associated hemolytic uremic syndrome in miceCarlamaria Zoja, Monica Locatelli, Chiara Pagani, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 5, 2026
4th workshop purification therapies, from research to clinics "the end of the beginning": executive summaryMauro Atti, Giuseppe Remuzzi, Giuseppe Feltrin, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Insulin resistance and proliferative retinopathy: a cross-sectional, case-control study in 115 patients with type 2 diabetesAneliya Parvanova, Ilian Iliev, Marco Filipponi, et al.
Frontiers in Pharmacology|March 17, 2022
Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19Valentina Fanny Leone, Amantia Imeraj, Sara Gastoldi, et al.
Diabetes|September 2, 2009
Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICTSalvatore De Cosmo, Nicola Motterlini, Sabrina Prudente, et al.
Diabetes|April 29, 2006
Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretionAneliya I Parvanova, Roberto Trevisan, Ilian P Iliev, et al.
Nephron|February 13, 2020
Morphofunctional Effects of C5 Convertase Blockade in Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Report of Two Cases with Evidence of Terminal Complement ActivationCamillo Carrara, Manuel Alfredo Podestà, Mauro Abbate, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 8, 2008
Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathyPiero Ruggenenti, Paolo Cravedi, Maria Chiara Sghirlanzoni, et al.
American Journal of Physiology. Renal Physiology|December 30, 2011
Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic miceChao-Sheng Lo, Fang Liu, Yixuan Shi, et al.
Diabetes|May 10, 2014
Catalase overexpression prevents nuclear factor erythroid 2-related factor 2 stimulation of renal angiotensinogen gene expression, hypertension, and kidney injury in diabetic miceShaaban Abdo, Yixuan Shi, Abouzar Otoukesh, et al.
Pageof 86